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interindividual variability.
The ratio C U /C N , an index of the concentration range over which Background. The choice of the correct concentration of potoxicity is exerted, exceeded 15 in the case of 20 compounds. The tential uremic toxins for in vitro, ex vivo, and in vivo experihighest values were registered for several guanidines, proteinments remains a major area of concern; errors at this level might bound compounds, and middle molecules, to a large extent result in incorrect decisions regarding therpeutic correction of compounds with known toxicity. A ratio of C MAX /C U Ͻ4, pointuremia and related clinical complications.
ing to a Gaussian distribution, was found for the majority of Methods. An encyclopedic list of uremic retention solutes the compounds (74/90; 82%). For some compounds, however, was composed, containing their mean normal concentration this ratio largely exceeded 4 [e.g., for leptin (6.81) or indole-(C N ), their highest mean/median uremic concentration (C U ), 3-acetic acid (10.37)], pointing to other influencing factors than their highest concentration ever reported in uremia (C MAX ), renal function, such as gender, genetic predisposition, proteoand their molecular weight. A literature search of 857 publicalytic breakdown, posttranslation modification, general conditions on uremic toxicity resulted in the selection of data retion, or nutritional status. ported in 55 publications on 90 compounds, published between Conclusion. Concentrations of retention solutes in uremia 1968 and 2002.
vary over a broad range, from nanograms per liter to grams per Results. For all compounds, C U and/or C MAX exceeded C N .
liter. Low concentrations are found especially for the middle Molecular weight was lower than 500 D for 68 compounds; of molecules. A substantial number of molecules are protein the remaining 22 middle molecules, 12 exceeded 12,000 D. C U bound and/or middle molecules, and many of these exert toxicranged from 32.0 ng/L (methionine-enkephalin) up to 2.3 g/L ity and are characterized by a high range of toxic over normal (urea) . C U in the ng/L range was found especially for the middle concentration (C U /C N ratio). Hence, uremic retention is a commolecules (10/22; 45.5%), compared with 2/68 (2.9%) for a plex problem that concerns many more solutes than the current molecular weight Ͻ500 D (P Ͻ 0.002). Twenty-five solutes markers of urea and creatinine alone. This list provides a basis for systematic analytic approaches to map the relative importance of the enlisted families of toxins.
retention of a large number of compounds, which under normal conditions are excreted by the healthy kidneys Uremic concentrations were all expressed as mean Ϯ might have relatively little clinical relevance. To over-SD, or if means were lacking, as median. If literature come these pitfalls, in the present publication, three lists data were expressed in mean Ϯ SEM, SEM was transare presented containing in total 90 retention solutes formed to SD according to the formula: together with their normal and uremic concentrations, SD ϭ SEM ϫ ͌(n Ϫ1) (Eq. 2) offering a "dictionary" of uremic retention solutes, in a standardized and homogeneous manner. The work has Our primary research was aimed at finding the highest been constructed as an objective report of the available reported mean/median uremic concentrations (C U ). These information, rather than as a critical analysis of how this values were noted, regardless of whether the patients reinformation has been obtained. The report is followed ported were in the predialytic stage, or dialysed by hemoby a number of reflections regarding the characteristics dialysis or peritoneal dialysis. If possible, the correspondand the retention pattern of the depicted molecules. The ing normal values (C N ) were extracted from the same aim is to offer a platform for more systematic future publications. If not available in these specific publicastudies in the area of uremic toxicity.
tions, normal values were collected from other sources.
If normal values were indicated in the publications as being below a given detection limit, this limit was intro-METHODS duced as the highest normal value. If normal values were A database of 857 publications, published between given as a range, also the highest value was taken as the 1966 and 2002, covering the field of uremic toxins and/or reference. In both cases, the normal value is accompauremic toxicity, was considered. The references were nied by the symbol "Ͻ" in the tables. In any other case, collected based on a Medline literature search (Refermeans Ϯ SD are given and the means were taken as the ence Manager 9) with as reference words (search items) reference value. Per C N , C U , or C MAX value, only one lit-"uremic toxins/uremic toxicity" and/or specific names of erature reference was finally to be used for data collecknown retention solutes as recently reviewed [1, 3, 5] .
tion, so that per molecule maximum three references This list was further completed based on the personal can be found. It, however, occurred only once that we had expertise of the authors. Among these publications, 149 to refer to three publications (homocysteine), whereas were devoted to solute concentration. Only plasma/serum the characteristic concentrations of most molecules were concentrations were taken into consideration.
only covered by one reference (N ϭ 67). For 22 molecules, A search was made to register a representative mean two references were used. or median normal concentration, a representative mean In addition, if available, the single highest uremic concentration ever reported was illustrated as well (C MAX The concentrations of in total 90 uremic solutes are C U values had been obtained, the molecular weight, the listed in Tables 1 to 3 . In Table 1 , results regarding 45 reference(s) from which the data had been collected, and low molecular weight solutes (molecular weight Ͻ500 D) (if available) the larger group to which the molecules bewithout known protein binding (small free water-soluble longed (e.g., guanidines, phenols, peptides) were reported. compounds) are summarized . Similarly, Table 2 Molecules were subdivided into three major classes:
contains data on 25 compounds with known protein bind-(1) small solutes (Ͻ500 D) with no known protein binding or belonging to groups of solutes that are known to be ing; (2) solutes with known or likely protein binding; protein bound [10, 11, 20, [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] . Most of these proteinand (3) middle molecules (Ն500 D). For all the proteinbound solutes are also characterized by a molecular weight bound solutes, only the total concentrations were illus-Ͻ500 D, although two of these compounds (leptin and trated.
retinol-binding protein) have a molecular weight conformThe lower cutoff value for the so-called middle moleing with that of the middle molecules. For these proteincules (500 D) was based on the original literature data bound compounds, the tables only contain total (free ϩ reporting on this class of uremic solutes [6] . In this literabound) concentrations. For several molecules, we found a discordance between with a molecular weight in excess of 2000 D were also the highest [13, 34, 63] and the lowest range of reported enlisted as middle molecules.
uremic concentrations [15, 36, 67] . The most striking Molecules that are not filterable through the glomeruexamples [asymmetric dimethylarginine (ADMA); inlar basement membrane because of their molecular size terleukin-6 (IL-6); 3-deoxyglucosone (3-DG)] are illus-(molecular weight Ͼ ϳ60,000 D) were not included [e.g., trated in Table 4 , where, in each instance, a discrepancy lipoprotein(a)]. Likewise, anorganic compounds were by a factor of 8 or more was observed. In Tables 1 to 3 excluded, although it is acknowledged that they can exert only the highest reported value is illustrated. It is of note toxicity (e.g., H 2 O, K ϩ , phosphate, trace elements). The that for ADMA, values intermediate between the lower reader is referred for these compounds to specific publirange as observed by Marescau et al [15] and the higher cations [7] [8] [9] . range observed by Kang et al [13] have been reported Furthermore, the ratio between mean uremic and norby Vallance et al [14] (approximately 878.5 g/L) and mal concentration was calculated (C U /C N ) to obtain an Zoccali et al [68] (777.7 g/L). index of the relative increase during uremia. In addition,
The uremic concentration of the 90 reported molealso the ratio of maximal over mean uremic concentracules was spread over a broad range, from 2.3 g/L [urea, tion (C MAX /C U ) was calculated. The latter index describes full urea concentration; for blood urea nitrogen (BUN) whether data distribution was Gaussian or not. Table 1 ). The range microgram per milligram (g/mg) protein [10, 11] . Since for the protein-bound solutes (N ϭ 25) extended from in these publications, however, no serum total protein 247.0 mg/L (hippuric acid) to 175.8 ng/L (melatonin) was mentioned, it was impossible to extrapolate the abso- (Table 2) , and for the middle molecules (N ϭ 22) from lute AGE concentrations. In these cases, absolute con-192.0 mg/L (retinal-binding protein) to 32.2 ng/L (methitent was calculated by multiplying with an average serum onine-enkephalin) (Table 3) The median concentration protein concentration (i.e., 70,000 mg/L). The reported value was 773.8 g/L overall (methylguanidine) and was AGE values all were obtained in uremic patient groups 1.2 mg/L for the small water-soluble compounds, as well without diabetes mellitus.
as for the protein-bound compounds, but only 0.95 g/L For statistical comparison, an Instat statistical packfor the middle molecules. Considering these medians, in age was used. Sets of values reported per group of molecules (small water-soluble, protein-bound, middle molegeneral, the concentration of the middle molecules was lower compared to the water-soluble and protein-bound are listed in Table 5 . The cutoff values for these lists were set arbitrarily. Among the eight compounds with solutes and this was confirmed by comparative statistical analysis (P ϭ 0.01 vs. small water-soluble compounds; the highest C U /C N index, there were two guanidines, three protein-bound solutes, and two middle molecules. Among P ϭ 0.02 vs. protein-bound compounds). For 10 out of 22 of the middle molecules (45.5%) uremic concentrathe 20 lowest scoring compounds, there were seven middle molecules. When considering the index per group of tion was in ng/L range, compared with 1 out of 45 small water-soluble compounds (2.2%; P Ͻ 0.001) and 1 out molecules, only the difference between protein-bound molecules and middle molecules was at the borderline of 25 protein-bound compounds (2.5%; P Ͻ 0.01).
The index C U /C N offers an indication about the differof significance (P ϭ 0.06). The index C MAX /C U indicates which solutes show a nonences between uremic and normal concentration values, over which toxicity can be exerted. The 20 solutes scoring Gaussian distribution, in a way that the highest ratios are obtained for the solutes with the most abnormal higher than 15 and the 19 solutes scoring lower than 2.5 Abbreviations are: C U , mean/median uremic concentration; C MAX , maximal uremic concentration; ADMA, asymmetrical dimethylarginine; IL-6, interleukin-6; 3-D6, 3-deoxyglucose. Abbreviations are: C U , mean/median uremic concentration; C N , normal concentration; ADMA, asymmetrical dimethylarginine. The cut-off values of 15 and Trimethylamine 2.5 were set arbitrarily. Solutes with a high score display a high differential concentration, uremic vs. normal, over which biologic activity (toxicity) can be exerted. Conversely, this range is limited for solutes displaying a low value. a C U /C N obtained with C N as a maximal (not as a mean) value exactly known and/or because their uremic retention has not been proven. ences between uremic and normal concentrations and The resulting lists are a striking illustration of the complexity of uremic retention. Obviously, there is more than the retention of a single compound or even a group of compounds, and also, there is more than the retention distribution. In Table 6 , the compounds with a C MAX /C U above or equal to 4.0 are displayed. It contains 17 comof the current markers, urea and creatinine. Without any doubt, clinical uremic toxicity is even more complex, pounds, four of which are guanidines, but also some middle molecules, such as leptin (6.81), IL-6 (6.84), and since a host of retained compounds remain unidentified. In the present inventory, uremic solutes are listed and hyaluronic acid (8.57) are included. We found no statistically significant differences among groups.
classified according to the characteristics that potentially influence their removal pattern during dialysis or other Finally, in Table 7 , a number of molecules to be considered for the future are listed. They do not figure in Tables methods of extracorporeal elimination (i.e., molecular weight and lipophilicity/hydrophilicity resulting in pro-1 to 3 because either their uremic concentration is not tein binding). The publication does not deal with bioture and, hence, also its binding capacity for other ligands [80] . Nevertheless, the relation with the binding proteins chemical or clinical relevance of the listed compounds, which has been presented by the same group of authors is probably different from that of other classical proteinbound solutes, such as indoxyl sulfate or p-cresol. The elsewhere [3] . The major practical impact of this work is as a tool for the future for any effort of in vitro or binding should be considered as more long-lived than for the other ligands, which display a continuous and in vivo evaluation of uremic toxicity. Furthermore, the information collected here might also be of help for dynamic competition among each other and with drugs for the protein-binding sites [81] [82] [83] . In some publications, kinetic evaluation and modeling of uremic toxin time courses for generation rate and their appearance in difnot only total concentrations but also free concentrations are reported for the AGEs [11, 56] . These values are by ferent compartments.
Our data clarify the need to approach the problem of definition much lower than the total concentration. More than 250-fold lower values were found for furosine, the uremic toxicity in a different way than has been done in the past, as analyses were essentially restricted to the free fraction of fructoselysine (201.1 Ϯ 73.1 g/L vs. 58.1 Ϯ 10.8 mg/L) [11] . The tables only contain total (free ϩ evaluation of one or a few molecules regarding their impact on one or a few biologic systems. The considerbound) concentrations.
One should be aware of the fact that the biologic ation of several compounds or groups of compounds at a time might conform more with reality. Hence, to solve action of protein-bound compounds is exerted by their free fraction. Hence, the total concentrations, as depicted the problem of uremic toxicity, collaborative studies involving different research groups with different scopes in the present tables, are only valid if the experimental medium contains a sufficient quantity of albumin (or of interest will be needed. Another aspect to be considered for the future is the intermutual interference of plasma protein). For in vitro experiments, it might be worthwhile to measure the free fraction in the final meuremic compounds, which might necessitate the study of solutes in a "uremic" rather than a "normal" milieu.
dium; however, usually only one solute will be added at a time, whereas in vivo many ligands will be present It is of note that molecules with a molecular weight exceeding 60,000 D (cutoff of the glomerular basement together, competing for the protein-binding sites and increasing the free fraction. membrane) and anorganic substances were excluded from the analysis. This, for example, eliminated lipoproOverall, molecular weights of the listed compounds extended from 60 D (urea) to 32,000 D (IL-1␤). Also tein (a) (molecular weight ϳ100,000 D), despite an enhanced concentration in uremia [69, 70] , and a potential concentrations extended over a broad range with as highest value urea, in the g/L range, and as the lowest methiofor biologic activity. Likewise, phosphate was excluded, despite a potential link to cardiovascular morbidity/mornine-enkephalin, in the ng/L range. A high concentration is not necessarily related to a strong biologic activity. tality [9, 71] .
Essentially, we discerned small water-soluble comThe two molecules with the highest concentrations (urea and creatinine) are known for their relatively limited pounds with a low molecular weight (Ͻ500 D), small protein-bound solutes, and middle molecules (Ն500 D).
biologic activity [1, 3] . Addition of urea to the dialysate at concentrations exceeding those encountered in uremia The two latter types of molecules are characterized by a reduced removal during standard dialysis with small had relatively little impact on the clinical status of the patients submitted to this regimen [84] . pore, low-flux membranes [72, 73] , compared to the small water-soluble compounds. Although not definitely con-
The index C U /C N offers an indication on the differences between uremic and normal values. The larger the gap clusive, circumstantial evidence suggests that membranes with a larger pore size are not only linked to a more effibetween the two values, and the larger the index, the larger the range over which biologic activity can be excient removal of larger molecules [73] [74] [75] , but also to an improvement of clinical status and/or survival [4, [76] [77] [78] .
erted, and the bigger the chance that biologic effects become apparent in vivo or in vitro. It is of note that a It is of note that a recent prospective study could not demonstrate, however, any difference in survival outhigh C U /C N is to a large extent characteristic of guanidines, protein-bound solutes, and middle molecules (alcome in patients treated with large pore vs. small pore dialyzers [79] .
together 13/20 of the solutes scoring Ͼ15), whereas many of these compounds exert substantial biologic activity Protein-bound molecules, on the other hand, are not very efficiently removed by any dialytic procedure [72] .
[1, 3]. Furthermore, all these molecules are characterized by a different intradialytic behavior compared to the As a consequence, their concentration can hardly be influenced in ESRD, so that their clinical impact could classical marker urea [27, 72, 73] . For protein-bound molecules the ratio C U /C N might never be studied appropriately in dialyzed uremics.
AGEs were classified among the protein-bound soleven become more important for the unbound and biologically active fraction, than for total concentration, as utes. AGEs have been shown to be bound to albumin and other proteins and may even change albumin struchas been observed for p-cresol [85] .
Hence, removal strategies should be designed in a way different mean uremic or highest values than the ones that not only the standard molecules, but also other reported here. For that matter, this database will need molecules that might be more important in the deterioracontinuous updating (see Acknowledgments). Neverthetion of the clinical condition, can be removed efficiently.
less, the present data offer, in our opinion, a broad over-A typical example is cardiovascular morbidity and morview of the present state of the art, and such an overview tality, at present one of the most worrying complications has, to our knowledge, never been published before. The of the uremic condition [3] . Careful analysis of the literaauthors will appreciate receiving additional information ture shows that most molecules held as yet responsible about new solutes to be added to the lists, or about for uremic toxicity are removed in a different way than enlisted molecules with reported concentrations that are urea and creatinine, either due to their molecular weight, different from the ones that are cited at present, enabling protein binding, and/or multicompartmental behavior a continuous update. [1, 3] . Subsequently, dialytic removal strategies should be adapted accordingly, based on a global knowledge of CONCLUSION the compounds playing a role in any complication of An overview is given on the reported range of concenuremia.
tration of uremic retention solutes. Most known uremic The index C MAX /C U indicates which solutes follow a retention solutes have a low molecular weight, although non-Gaussian distribution. The higher the value of this these not necessarily exert toxicity, especially if they index, the more abnormal the distribution of concentraare not protein bound. Concentrations of 90 solutes are tions. This might be the consequence of various interferreported, ranging from 2.3 g/L (urea) to 0.32 ng/L (methiing factors that are not necessarily related to the uremic status (e.g., gender, genetic predisposition, general cononine-enkephalin). Low concentrations are found espedition, body composition, or nutritional status) [46, 86- cially for the middle molecules. The ratio C U /C N is high 88]. Several guanidines and middle molecules show a for several of the guanidines, protein-bound molecules, strong trend for abnormal distribution. Among these, and middle molecules, and many of these solutes are IL-6 and leptin may have an important potential for toxic. These data can be of use as a guideline for future biologic activity [3] .
in vivo and in vitro experiments. Uremic retention apIt is of note that for certain solutes a substantial gap pears to be a complex kinetic and multifactorial problem exists between the highest reported mean concentrations concerning a larger amount of solutes than those cur- [13, 34, 63] and the other reported concentrations [15, rently used as markers, such as urea and creatinine. 36, 67] . This is the case for ADMA, IL-6, and 3-DG (Table 4) . We considered it beyond the scope of this ACKNOWLEDGMENTS work to offer a critical analysis on the origin(s) of these procedures (e.g., absorption on chromatographic columns E-mail: raymond.vanholder@rug.ac.be or evaporation). Whether the discrepancies reported in Table 4 are attributable to technical reasons, or to differ-REFERENCES ences in patient populations or removal strategies, is left pounds and/or known compounds will be presented with
